RPG Life Sciences Completes ₹243.33 Crore Stake Sale in Subsidiary RPGAP
RPG Life Sciences Ltd · Others (Uncategorized) · 10 Sept 2026, 4:20 am
RPG Life Sciences Completes ₹243.33 Crore Stake Sale in Subsidiary RPGAP RPG Life Sciences announced that its subsidiary, RPG Active Pharma Limited (RPGAP), allotted securities to India Life Sciences Fund IV Domestic and Vistaject Fund on 9th Sep'26. The transaction raised a total consideration of INR 243.33 crores, representing a 40% equity stake in RPGAP pursuant to the investment agreement dated 29th Jul'26. Following this allotment, RPGAP continues to operate as a subsidiary of RPG Life Sciences.
Original exchange filing (PDF)
More announcements from RPG Life Sciences Ltd
- Earning call Transcript · 05 Nov 2026
- Audio Recording of Q2FY27 Results Earnings Call held on October 30, 2026 · 31 Oct 2026
- Investor Presentation · 30 Oct 2026
- Amendment to Policy on Related Party Transactions · 30 Oct 2026
- Press Release · 30 Oct 2026
- Outcome of Board Meeting held on October 29, 2026. · 30 Oct 2026
- Financial Result for the quarter ended September 30, 2026 · 30 Oct 2026
- Outcome of Board Meeting · 30 Oct 2026
